help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehtonen, J. Y. A.
Right arrow Articles by Dzau, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehtonen, J. Y. A.
Right arrow Articles by Dzau, V. J.
Molecular Endocrinology 13 (7): 1051-1060
Copyright © 1999 by The Endocrine Society

Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis

Jukka Y. A. Lehtonen1, Laurent Daviet1, Clara Nahmias, Masatsugu Horiuchi and Victor J. Dzau

Division of Cardiovascular Medicine (J.Y.A.L., L.D., M.H., V.J.D.) Harvard Medical School Brigham and Women’s Hospital Boston, Massachusetts 02115
Institut Cochin de Génétique Moléculaire (C.N.) Centre Nationale de Recherche Scientifique UPR 0415 75014 Paris, France

We previously demonstrated that the intracellular third loop (i3 loop) of angiotensin II type 2 receptor (AT2) plays a key role in mediating the biological functions of this receptor. To determine which residues are important for AT2 signaling, mutated receptors with serial deletions within the i3 loop were stably expressed in PC12 cells. Deletion of residues 240–244 within the intermediate portion of the i3 loop resulted in a complete loss of AT2-mediated apoptosis, inhibition of extracellular signal-regulated kinases (ERK), and SHP-1 activation. In contrast to well characterized heptahelical receptors, the AT2 functions were not affected by deletions of the amino- or carboxyl-terminal portions of the i3 loop. Alanine substitutions further demonstrated that lysine 240, asparagine 242, and serine 243 are key residues for AT2-induced apoptosis, ERK inhibition, and SHP-1 activation. To examine whether a functional link exists between activation of SHP-1 and apoptosis, we used a catalytically inactive SHP-1 mutant and demonstrated that preventing SHP-1 activation strongly attenuates AT2-induced ERK inhibition and apoptosis. Our data demonstrate that the intermediate portion of the i3 loop is important for AT2 function and that SHP-1 is a proximal effector of the AT2 receptor that is implicated in the inhibition of ERKs and in the apoptotic effect of this receptor.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
M. Backlund, K. Paukku, L. Daviet, R. A. De Boer, E. Valo, S. Hautaniemi, N. Kalkkinen, A. Ehsan, K. K. Kontula, and J. Y. A. Lehtonen
Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase
Nucleic Acids Res., April 1, 2009; 37(7): 2346 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Mogi, M. Iwai, and M. Horiuchi
Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2532 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J.-M. Li, M. Mogi, K. Tsukuda, H. Tomochika, J. Iwanami, L.-J. Min, C. Nahmias, M. Iwai, and M. Horiuchi
Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1
Mol. Endocrinol., February 1, 2007; 21(2): 499 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. J. Wruck, H. Funke-Kaiser, T. Pufe, H. Kusserow, M. Menk, J. H. Schefe, M. L. Kruse, M. Stoll, and T. Unger
Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein
Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 57 - 64.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Nouet, N. Amzallag, J.-M. Li, S. Louis, I. Seitz, T.-X. Cui, A.-M. Alleaume, M. Di Benedetto, C. Boden, M. Masson, et al.
Trans-inactivation of Receptor Tyrosine Kinases by Novel Angiotensin II AT2 Receptor-interacting Protein, ATIP
J. Biol. Chem., July 9, 2004; 279(28): 28989 - 28997.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. B. Marrero, R. L. Papke, B. S. Bhatti, S. Shaw, and M. Bencherif
The Neuroprotective Effect of 2-(3-Pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a Novel {alpha}7 Ligand, Is Prevented through Angiotensin II Activation of a Tyrosine Phosphatase
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 16 - 27.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
L. Wu, M. Iwai, Z. Li, T. Shiuchi, L.-J. Min, T.-X. Cui, J.-M. Li, M. Okumura, C. Nahmias, and M. Horiuchi
Regulation of Inhibitory Protein-{kappa}B and Monocyte Chemoattractant Protein-1 by Angiotensin II Type 2 Receptor-Activated Src Homology Protein Tyrosine Phosphatase-1 in Fetal Vascular Smooth Muscle Cells
Mol. Endocrinol., March 1, 2004; 18(3): 666 - 678.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L.-J. Min, T.-X. Cui, Y. Yahata, K. Yamasaki, T. Shiuchi, H.-W. Liu, R. Chen, J.-M. Li, M. Okumura, T. Jinno, et al.
Regulation of Collagen Synthesis in Mouse Skin Fibroblasts by Distinct Angiotensin II Receptor Subtypes
Endocrinology, January 1, 2004; 145(1): 253 - 260.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Shaw, M. Bencherif, and M. B. Marrero
Angiotensin II Blocks Nicotine-Mediated Neuroprotection against {beta}-Amyloid (1-42) via Activation of the Tyrosine Phosphatase SHP-1
J. Neurosci., December 3, 2003; 23(35): 11224 - 11228.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. Tian, J. Liu, P. Bitterman, and R. J. Bache
Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1105 - H1112.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y.-H. Feng, Y. Sun, and J. G. Douglas
Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1
PNAS, September 17, 2002; 99(19): 12049 - 12054.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T.-X. Cui, H. Nakagami, C. Nahmias, T. Shiuchi, Y. Takeda-Matsubara, J.-M. Li, L. Wu, M. Iwai, and M. Horiuchi
Angiotensin II Subtype 2 Receptor Activation Inhibits Insulin-Induced Phosphoinositide 3-Kinase and Akt and Induces Apoptosis in PC12W Cells
Mol. Endocrinol., September 1, 2002; 16(9): 2113 - 2123.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Nakagami, T.-X. Cui, M. Iwai, T. Shiuchi, Y. Takeda-Matsubara, L. Wu, and M. Horiuchi
Tumor Necrosis Factor-{alpha} Inhibits Growth Factor-Mediated Cell Proliferation Through SHP-1 Activation in Endothelial Cells
Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 238 - 242.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Takeda-Matsubara, H. Nakagami, M. Iwai, T.-X. Cui, T. Shiuchi, M. Akishita, C. Nahmias, M. Ito, and M. Horiuchi
Estrogen Activates Phosphatases and Antagonizes Growth-Promoting Effect of Angiotensin II
Hypertension, January 1, 2002; 39(1): 41 - 45.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. AbdAlla, H. Lother, A. M. Abdel-tawab, and U. Quitterer
The Angiotensin II AT2 Receptor Is an AT1 Receptor Antagonist
J. Biol. Chem., October 19, 2001; 276(43): 39721 - 39726.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Shibasaki, H. Matsubara, Y. Nozawa, Y. Mori, H. Masaki, A. Kosaki, Y. Tsutsumi, Y. Uchiyama, S. Fujiyama, A. Nose, et al.
Angiotensin II Type 2 Receptor Inhibits Epidermal Growth Factor Receptor Transactivation by Increasing Association of SHP-1 Tyrosine Phosphatase
Hypertension, September 1, 2001; 38(3): 367 - 372.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. Dalla Libera, B. Ravara, A. Angelini, K. Rossini, M. Sandri, G. Thiene, G. Battista Ambrosio, and G. Vescovo
Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure
Circulation, May 1, 2001; 103(17): 2195 - 2200.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T.-X. Cui, H. Nakagami, M. Iwai, Y. Takeda, T. Shiuchi, L. Daviet, C. Nahmias, and M. Horiuchi
Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell
Cardiovasc Res, March 1, 2001; 49(4): 863 - 871.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. L. Hansen, G. Servant, T. J. Baranski, T. Fujita, T. Iiri, and S. P. Sheikh
Functional Reconstitution of the Angiotensin II Type 2 Receptor and Gi Activation
Circ. Res., October 27, 2000; 87(9): 753 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
N. Elbaz, K. Bedecs, M. Masson, M. Sutren, A. D. Strosberg, and C. Nahmias
Functional Trans-inactivation of Insulin Receptor Kinase by Growth-Inhibitory Angiotensin II AT2 Receptor
Mol. Endocrinol., June 1, 2000; 14(6): 795 - 804.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners
The angiotensin II type 2 receptor: an enigma with multiple variations
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society